GeneDx Holdings Corp. (WGS) stock
WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)
Close on Nov 16, 2026Market cap $1.52BP/E –Yield –
GeneDx profit margin
Profit margin (net margin) is net income as a percentage of revenue.
GeneDx's profit margin for the twelve months ending Jun 30, 2026 was -23.4%. For fiscal 2025 it was -4.9%, against -17.1% the year before. The highest annual figure on record is -4.9% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4.9% | +12.2 |
| FY2024 | Dec 31, 2024 | -17.1% | +69.7 |
| FY2023 | Dec 31, 2023 | -86.8% | +147.1 |
| FY2022 | Dec 31, 2022 | -233.9% | −118.3 |
| FY2021 | Dec 31, 2021 | -115.6% | +18.9 |
| FY2020 | Dec 31, 2020 | -134.6% | −119.4 |
| FY2019 | Dec 31, 2019 | -15.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -15.5% | −26.0 |
| Q1 FY2026 | Mar 31, 2026 | -61.9% | −54.4 |
| Q4 FY2025 | Dec 31, 2025 | -14.6% | −20.3 |
| Q3 FY2025 | Sep 30, 2025 | -6.5% | +4.3 |
| Q2 FY2025 | Jun 30, 2025 | 10.5% | +51.9 |
| Q1 FY2025 | Mar 31, 2025 | -7.5% | +24.9 |
| Q4 FY2024 | Dec 31, 2024 | 5.7% | +50.6 |
| Q3 FY2024 | Sep 30, 2024 | -10.8% | +68.5 |
| Q2 FY2024 | Jun 30, 2024 | -41.4% | +54.5 |
| Q1 FY2024 | Mar 31, 2024 | -32.4% | +109.0 |
| Q4 FY2023 | Dec 31, 2023 | -44.9% | +458.4 |
| Q3 FY2023 | Sep 30, 2023 | -79.3% | +13.9 |
| Q2 FY2023 | Jun 30, 2023 | -95.9% | +141.1 |
| Q1 FY2023 | Mar 31, 2023 | -141.4% | +1.2 |
| Q4 FY2022 | Dec 31, 2022 | -503.3% | −433.8 |
| Q3 FY2022 | Sep 30, 2022 | -93.2% | −169.0 |
| Q2 FY2022 | Jun 30, 2022 | -237.1% | −138.9 |
| Q1 FY2022 | Mar 31, 2022 | -142.6% | +156.2 |
| Q4 FY2021 | Dec 31, 2021 | -69.5% | +127.0 |
| Q3 FY2021 | Sep 30, 2021 | 75.8% | +222.4 |
| Q2 FY2021 | Jun 30, 2021 | -98.2% | +8.3 |
| Q1 FY2021 | Mar 31, 2021 | -298.7% | −240.9 |
| Q4 FY2020 | Dec 31, 2020 | -196.5% | – |
| Q3 FY2020 | Sep 30, 2020 | -146.6% | – |
| Q2 FY2020 | Jun 30, 2020 | -106.5% | – |
| Q1 FY2020 | Mar 31, 2020 | -57.9% | – |
See a number that looks wrong?